Literature DB >> 24639348

Chemokine cooperativity is caused by competitive glycosaminoglycan binding.

Guido J R Zaman1, Martine J Smit2, Folkert Verkaar2,3, Jody van Offenbeek2,3, Miranda M C van der Lee3, Lambertus H C J van Lith3, Anne O Watts2, Angelique L W M M Rops4, David C Aguilar5, Joshua J Ziarek6, Johan van der Vlag4, Tracy M Handel5, Brian F Volkman6, Amanda E I Proudfoot7, Henry F Vischer2.   

Abstract

Chemokines comprise a family of secreted proteins that activate G protein-coupled chemokine receptors and thereby control the migration of leukocytes during inflammation or immune surveillance. The positional information required for such migratory behavior is governed by the binding of chemokines to membrane-tethered glycosaminoglycans (GAGs), which establishes a chemokine concentration gradient. An often observed but incompletely understood behavior of chemokines is the ability of unrelated chemokines to enhance the potency with which another chemokine subtype can activate its cognate receptor. This phenomenon has been demonstrated to occur between many chemokine combinations and across several model systems and has been dubbed chemokine cooperativity. In this study, we have used GAG binding-deficient chemokine mutants and cell-based functional (migration) assays to demonstrate that chemokine cooperativity is caused by competitive binding of chemokines to GAGs. This mechanistic explanation of chemokine cooperativity provides insight into chemokine gradient formation in the context of inflammation, in which multiple chemokines are secreted simultaneously.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24639348      PMCID: PMC4198333          DOI: 10.4049/jimmunol.1302159

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

Review 1.  Chemokines and chemokine receptors in infectious diseases.

Authors:  S Mahalingam; G Karupiah
Journal:  Immunol Cell Biol       Date:  1999-12       Impact factor: 5.126

2.  Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin.

Authors:  J L Pablos; A Amara; A Bouloc; B Santiago; A Caruz; M Galindo; T Delaunay; J L Virelizier; F Arenzana-Seisdedos
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 3.  The molecular basis and functional implications of chemokine interactions with heparan sulphate.

Authors:  Hugues Lortat-Jacob
Journal:  Curr Opin Struct Biol       Date:  2009-09-30       Impact factor: 6.809

4.  β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.

Authors:  Anne O Watts; Folkert Verkaar; Miranda M C van der Lee; Claudia A W Timmerman; Martien Kuijer; Jody van Offenbeek; Lambertus H C J van Lith; Martine J Smit; Rob Leurs; Guido J R Zaman; Henry F Vischer
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

5.  Glycosaminoglycans mediate cell surface oligomerization of chemokines.

Authors:  A J Hoogewerf; G S Kuschert; A E Proudfoot; F Borlat; I Clark-Lewis; C A Power; T N Wells
Journal:  Biochemistry       Date:  1997-11-04       Impact factor: 3.162

6.  Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.

Authors:  Lan-Yun Feng; Zhou-Luo Ou; Feng-Ying Wu; Zhen-Zhou Shen; Zhi-Ming Shao
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

7.  IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation.

Authors:  Anne Krug; Ravindra Uppaluri; Fabio Facchetti; Brigitte G Dorner; Kathleen C F Sheehan; Robert D Schreiber; Marina Cella; Marco Colonna
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

Review 8.  Heparan sulfate proteoglycans in glomerular inflammation.

Authors:  Angelique L W M M Rops; Johan van der Vlag; Joost F M Lensen; Tessa J M Wijnhoven; Lambert P W J van den Heuvel; Toin H van Kuppevelt; Jo H M Berden
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

9.  Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events.

Authors:  Mieke Gouwy; Sofie Struyf; Samuel Noppen; Evemie Schutyser; Jean-Yves Springael; Marc Parmentier; Paul Proost; Jo Van Damme
Journal:  Mol Pharmacol       Date:  2008-05-09       Impact factor: 4.436

10.  Ubiquitination of CXCR7 controls receptor trafficking.

Authors:  Meritxell Canals; Danny J Scholten; Sabrina de Munnik; Mitchell K L Han; Martine J Smit; Rob Leurs
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

View more
  15 in total

1.  Pro-angiogenic effects of pregnancy-specific glycoproteins in endothelial and extravillous trophoblast cells.

Authors:  Shemona Rattila; Florian Kleefeldt; Angela Ballesteros; Jimena S Beltrame; Maria L Ribeiro; Süleyman Ergün; Gabriela Dveksler
Journal:  Reproduction       Date:  2020-11       Impact factor: 3.906

2.  Role of the C-C chemokine receptor-2 in a murine model of injury-induced osteoarthritis.

Authors:  L Longobardi; J D Temple; L Tagliafierro; H Willcockson; A Esposito; N D'Onofrio; E Stein; T Li; T J Myers; H Ozkan; M L Balestrieri; V Ulici; R F Loeser; A Spagnoli
Journal:  Osteoarthritis Cartilage       Date:  2016-11-14       Impact factor: 6.576

Review 3.  Modulation of Chemokine Responses: Synergy and Cooperativity.

Authors:  Amanda E I Proudfoot; Mariagrazia Uguccioni
Journal:  Front Immunol       Date:  2016-05-19       Impact factor: 7.561

Review 4.  Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26.

Authors:  Mieke Metzemaekers; Jo Van Damme; Anneleen Mortier; Paul Proost
Journal:  Front Immunol       Date:  2016-11-11       Impact factor: 7.561

Review 5.  Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System.

Authors:  Amanda E I Proudfoot; Zoë Johnson; Pauline Bonvin; Tracy M Handel
Journal:  Pharmaceuticals (Basel)       Date:  2017-08-09

6.  CXCL9-Derived Peptides Differentially Inhibit Neutrophil Migration In Vivo through Interference with Glycosaminoglycan Interactions.

Authors:  Vincent Vanheule; Daiane Boff; Anneleen Mortier; Rik Janssens; Björn Petri; Elzbieta Kolaczkowska; Paul Kubes; Nele Berghmans; Sofie Struyf; Andreas J Kungl; Mauro Martins Teixeira; Flavio Almeida Amaral; Paul Proost
Journal:  Front Immunol       Date:  2017-05-10       Impact factor: 7.561

7.  Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration.

Authors:  Víctor González-Motos; Carina Jürgens; Birgit Ritter; Kai A Kropp; Verónica Durán; Olav Larsen; Anne Binz; Werner J D Ouwendijk; Tihana Lenac Rovis; Stipan Jonjic; Georges M G M Verjans; Beate Sodeik; Thomas Krey; Rudolf Bauerfeind; Thomas F Schulz; Benedikt B Kaufer; Ulrich Kalinke; Amanda E I Proudfoot; Mette M Rosenkilde; Abel Viejo-Borbolla
Journal:  PLoS Pathog       Date:  2017-05-25       Impact factor: 6.823

8.  Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function.

Authors:  You-Hong Cheng; Jonathan M Eby; Heather M LaPorte; Brian F Volkman; Matthias Majetschak
Journal:  PLoS One       Date:  2017-11-10       Impact factor: 3.240

Review 9.  Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise.

Authors:  Palak J Trivedi; David H Adams
Journal:  J Crohns Colitis       Date:  2018-08-22       Impact factor: 9.071

Review 10.  Chemokines from a Structural Perspective.

Authors:  Michelle C Miller; Kevin H Mayo
Journal:  Int J Mol Sci       Date:  2017-10-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.